544629 — Ravelcare Income Statement
0.000.00%
- IN₹848.12m
- IN₹837.90m
- IN₹269.54m
Annual income statement for Ravelcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 34.9 | 221 | 250 | 270 |
| Cost of Revenue | ||||
| Gross Profit | 27.3 | 156 | 198 | 208 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 29.9 | 155 | 182 | 200 |
| Operating Profit | 5.06 | 66.2 | 67.4 | 69.9 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 5.06 | 68.1 | 70.4 | 70.7 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 4.15 | 50.2 | 52.6 | 51.5 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 4.15 | 50.2 | 52.6 | 51.5 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 4.15 | 50.2 | 52.6 | 51.5 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.605 | 7.32 | 7.66 | 9.2 |